• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oncothyreon Inc

+ Add to Watchlist

ONTY:US

3.0000 USD 0.0600 1.96%

As of 15:40:32 ET on 07/25/2014.

Snapshot for Oncothyreon Inc (ONTY)

Open: 3.0300 Day's Range: 2.9950 - 3.1200 Volume: 215,360
Previous Close: 3.0600 52wk Range: 1.5700 - 4.0800 1-Yr Rtn: +88.68%

Stock Chart for ONTY

No chart data available.
  • ONTY:US 3.0100
  • 1D
  • 1M
  • 1Y
3.0600
Interactive ONTY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ONTY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6350
Est. EPS (USD) (12/2014) -0.5050
Est. PEG Ratio -
Market Cap (M USD) 212.25
Shares Outstanding (M) 70.75
30 Day Average Volume 836,358
Price/Book (mrq) 3.3854
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ONTY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ONTY

Oncothyreon Inc. develops therapeutic approaches to cancer management. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer. Oncothyreon delivers its services to customers throughout the United States.

Robert L KirkmanPresident/CEOGary ChristiansonChief Operating Officer
Diana HausmanChief Medical OfficerScott PetersonChief Scientific Officer
More Company Profile & Key Executives for ONTY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil